Molecular and cellular aspects of troponin cardiomyopathies

Aldrin V Gomes, James D. Potter

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Advances in molecular genetics have led to the identification of mutations in each troponin subunit that cause different human cardiomyopathies. Mutations in the genes for cardiac troponin T (CTnT), troponin I (CTnI), and troponin C (CTnC) cause familial hypertrophic cardiomyopathy (FHC) and are associated with varying prognosis and mild-to-moderate hypertrophy. Mutations in CTnT and CTnC can also cause dilated cardiomyopathy (DCM), whereas mutations in CTnI can cause restrictive cardiomyopathy (RCM). All together, 60 mutations have so far been found in troponin subunits associated with cardiomyopathy. Recently, multiple cardiomyopathic phenotypes (either HCM or RCM), arising from a single nucleotide mutation in the same codon of CTnI, R145, have been documented. Although the clinical phenotypes of the cardiomyopathies vary, two common features are present in most cardiomyopathy patients: altered Ca2+ sensitivity of force development and impaired energy metabolism. Here, we present the analyses of how these troponin mutations affect the in vitro contractile protein function and the hypotheses derived to explain the development of these disease states.

Original languageEnglish (US)
Pages (from-to)214-224
Number of pages11
JournalAnnals of the New York Academy of Sciences
Volume1015
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Troponin
Troponin I
Cardiomyopathies
Troponin C
Troponin T
Mutation
Contractile Proteins
Restrictive Cardiomyopathy
Nucleotides
Genes
Familial Hypertrophic Cardiomyopathy
Phenotype
Dilated Cardiomyopathy
Codon
Hypertrophy
Energy Metabolism
Molecular Biology
Causes

Keywords

  • Calcium
  • Dilated cardiomyopathy
  • Familial hypertrophic cardiomyopathy
  • Restrictive cardiomyopathy
  • Troponin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Molecular and cellular aspects of troponin cardiomyopathies. / Gomes, Aldrin V; Potter, James D.

In: Annals of the New York Academy of Sciences, Vol. 1015, 2004, p. 214-224.

Research output: Contribution to journalArticle

Gomes, Aldrin V ; Potter, James D. / Molecular and cellular aspects of troponin cardiomyopathies. In: Annals of the New York Academy of Sciences. 2004 ; Vol. 1015. pp. 214-224.
@article{9ee9a62b5048442a83e9cd2e2c823ee2,
title = "Molecular and cellular aspects of troponin cardiomyopathies",
abstract = "Advances in molecular genetics have led to the identification of mutations in each troponin subunit that cause different human cardiomyopathies. Mutations in the genes for cardiac troponin T (CTnT), troponin I (CTnI), and troponin C (CTnC) cause familial hypertrophic cardiomyopathy (FHC) and are associated with varying prognosis and mild-to-moderate hypertrophy. Mutations in CTnT and CTnC can also cause dilated cardiomyopathy (DCM), whereas mutations in CTnI can cause restrictive cardiomyopathy (RCM). All together, 60 mutations have so far been found in troponin subunits associated with cardiomyopathy. Recently, multiple cardiomyopathic phenotypes (either HCM or RCM), arising from a single nucleotide mutation in the same codon of CTnI, R145, have been documented. Although the clinical phenotypes of the cardiomyopathies vary, two common features are present in most cardiomyopathy patients: altered Ca2+ sensitivity of force development and impaired energy metabolism. Here, we present the analyses of how these troponin mutations affect the in vitro contractile protein function and the hypotheses derived to explain the development of these disease states.",
keywords = "Calcium, Dilated cardiomyopathy, Familial hypertrophic cardiomyopathy, Restrictive cardiomyopathy, Troponin",
author = "Gomes, {Aldrin V} and Potter, {James D.}",
year = "2004",
doi = "10.1196/annals.1302.018",
language = "English (US)",
volume = "1015",
pages = "214--224",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Molecular and cellular aspects of troponin cardiomyopathies

AU - Gomes, Aldrin V

AU - Potter, James D.

PY - 2004

Y1 - 2004

N2 - Advances in molecular genetics have led to the identification of mutations in each troponin subunit that cause different human cardiomyopathies. Mutations in the genes for cardiac troponin T (CTnT), troponin I (CTnI), and troponin C (CTnC) cause familial hypertrophic cardiomyopathy (FHC) and are associated with varying prognosis and mild-to-moderate hypertrophy. Mutations in CTnT and CTnC can also cause dilated cardiomyopathy (DCM), whereas mutations in CTnI can cause restrictive cardiomyopathy (RCM). All together, 60 mutations have so far been found in troponin subunits associated with cardiomyopathy. Recently, multiple cardiomyopathic phenotypes (either HCM or RCM), arising from a single nucleotide mutation in the same codon of CTnI, R145, have been documented. Although the clinical phenotypes of the cardiomyopathies vary, two common features are present in most cardiomyopathy patients: altered Ca2+ sensitivity of force development and impaired energy metabolism. Here, we present the analyses of how these troponin mutations affect the in vitro contractile protein function and the hypotheses derived to explain the development of these disease states.

AB - Advances in molecular genetics have led to the identification of mutations in each troponin subunit that cause different human cardiomyopathies. Mutations in the genes for cardiac troponin T (CTnT), troponin I (CTnI), and troponin C (CTnC) cause familial hypertrophic cardiomyopathy (FHC) and are associated with varying prognosis and mild-to-moderate hypertrophy. Mutations in CTnT and CTnC can also cause dilated cardiomyopathy (DCM), whereas mutations in CTnI can cause restrictive cardiomyopathy (RCM). All together, 60 mutations have so far been found in troponin subunits associated with cardiomyopathy. Recently, multiple cardiomyopathic phenotypes (either HCM or RCM), arising from a single nucleotide mutation in the same codon of CTnI, R145, have been documented. Although the clinical phenotypes of the cardiomyopathies vary, two common features are present in most cardiomyopathy patients: altered Ca2+ sensitivity of force development and impaired energy metabolism. Here, we present the analyses of how these troponin mutations affect the in vitro contractile protein function and the hypotheses derived to explain the development of these disease states.

KW - Calcium

KW - Dilated cardiomyopathy

KW - Familial hypertrophic cardiomyopathy

KW - Restrictive cardiomyopathy

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=3042718653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042718653&partnerID=8YFLogxK

U2 - 10.1196/annals.1302.018

DO - 10.1196/annals.1302.018

M3 - Article

C2 - 15201162

AN - SCOPUS:3042718653

VL - 1015

SP - 214

EP - 224

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -